Exceptional Results from Validation Study for EchoSolv HF

▪ Clinical validation successfully completed with Mayo Clinic Platform’s Validate program – marking the final clinical requirement prior to FDA 510(k) submission ▪ EchoSolv HF validation met the primary endpoint, delivering performance exceeding company expectations in detecting heart failure on an independent dataset ▪ Study was undertaken across 17,000 individual patient echocardiograms from the